Odense, Denmark | It only takes about 15 minutes to drive from the centre of Odense, a Danish university town, into the farmland that skirts it. But it’s enough time, as always, to strike up conversation with a taxi driver.
He learns I’m an Aussie, and isn’t surprised. “I’ve driven Australians out here before,” he says.
Here” is a large collection of greenhouses overlooked by a compact, functional office building and a couple of bungalows that pre-date the site’s industrial development.
Unbeknownst to this cabbie, the greenhouses are teeming not with tomatoes or strawberries, but the tall, fragrant flowers of cannabis.
Only the sign at the gate gives away that we have arrived at the perhaps unlikely European outpost of Perth-based, ASX-listed medicinal cannabis company Little Green Pharma.
For LGP’s spirited founder and chief executive Fleta Solomon, who was visiting the site this month with her board, this facility is at the centre of her ambition to nurture her seven-year-old start-up into a European market leader.
“Europe will be the biggest medicinal cannabis market outside of North America, but it’s still in its infancy, it’s still emerging. We just wanted to be here,” she says.
